EAM
ZYME icon

Eventide Asset Management’s Zymeworks ZYME Stock Holding History

Eventide Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,380,200
Closed -$33.1M – 158
2022
Q3 		$33.1M Hold
5,380,200
– – 0.65% 52
2022
Q2 		$28.5M Hold
5,380,200
– – 0.61% 57
2022
Q1 		$35.2M Buy
5,380,200
+2,561,065
+91% +$22.8M 0.55% 58
2021
Q4 		$46.2M Sell
2,819,135
-910,054
-24% -$19M 0.59% 57
2021
Q3 		$108M Buy
3,729,189
+528,461
+17% +$17.6M 1.43% 24
2021
Q2 		$111M Buy
3,200,728
+1,802,774
+129% +$57.2M 1.49% 20
2021
Q1 		$44.1M Buy
+1,397,954
New +$56.8M 0.65% 58

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eventide Asset Management's ZYME Position: Q4 2022 in Review

Eventide Asset Management sold out of Zymeworks (ZYME) in Q4 2022, closing a stake of 5,380,200 shares — an estimated $33.1M sold.

Eventide Asset Management first reported a position in ZYME in Q1 2021 and held it in 7 quarters. The position peaked at $111M in Q2 2021. 96 funds tracked by Wall St. Rank hold ZYME as of Q4 2022.

  • Eventide Asset Management reported no remaining Zymeworks position as of Q4 2022 after selling out during the quarter.
  • Eventide Asset Management sold 5,380,200 Zymeworks shares in Q4 2022, an estimated $33.1M.
  • Eventide Asset Management first reported a position in Zymeworks in Q1 2021 and held it in 7 quarters.
  • Eventide Asset Management's Zymeworks position peaked at $111M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Zymeworks as of Q4 2022.

Based on Eventide Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.